229 related articles for article (PubMed ID: 11075819)
1. MEKK1 activation of human estrogen receptor alpha and stimulation of the agonistic activity of 4-hydroxytamoxifen in endometrial and ovarian cancer cells.
Lee H; Jiang F; Wang Q; Nicosia SV; Yang J; Su B; Bai W
Mol Endocrinol; 2000 Nov; 14(11):1882-96. PubMed ID: 11075819
[TBL] [Abstract][Full Text] [Related]
2. Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation.
Lee H; Bai W
Mol Cell Biol; 2002 Aug; 22(16):5835-45. PubMed ID: 12138194
[TBL] [Abstract][Full Text] [Related]
3. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
Vivacqua A; Bonofiglio D; Recchia AG; Musti AM; Picard D; Andò S; Maggiolini M
Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
[TBL] [Abstract][Full Text] [Related]
4. Effect of prolonged hydroxytamoxifen treatment of MCF-7 cells on mitogen activated kinase cascade.
Rabenoelina F; Semlali A; Duchesne MJ; Freiss G; Pons M; Badia E
Int J Cancer; 2002 Apr; 98(5):698-706. PubMed ID: 11920638
[TBL] [Abstract][Full Text] [Related]
5. Expression of human cystatin A by keratinocytes is positively regulated via the Ras/MEKK1/MKK7/JNK signal transduction pathway but negatively regulated via the Ras/Raf-1/MEK1/ERK pathway.
Takahashi H; Honma M; Ishida-Yamamoto A; Namikawa K; Kiyama H; Iizuka H
J Biol Chem; 2001 Sep; 276(39):36632-8. PubMed ID: 11451947
[TBL] [Abstract][Full Text] [Related]
6. MEKK1 signaling through p38 leads to transcriptional inactivation of E47 and repression of skeletal myogenesis.
Page JL; Wang X; Sordillo LM; Johnson SE
J Biol Chem; 2004 Jul; 279(30):30966-72. PubMed ID: 15159407
[TBL] [Abstract][Full Text] [Related]
7. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
[TBL] [Abstract][Full Text] [Related]
8. Involvement of Asp-Glu-Val-Asp-directed, caspase-mediated mitogen-activated protein kinase kinase 1 Cleavage, c-Jun N-terminal kinase activation, and subsequent Bcl-2 phosphorylation for paclitaxel-induced apoptosis in HL-60 cells.
Shiah SG; Chuang SE; Kuo ML
Mol Pharmacol; 2001 Feb; 59(2):254-62. PubMed ID: 11160861
[TBL] [Abstract][Full Text] [Related]
9. Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.
Hammaker DR; Boyle DL; Chabaud-Riou M; Firestein GS
J Immunol; 2004 Feb; 172(3):1612-8. PubMed ID: 14734742
[TBL] [Abstract][Full Text] [Related]
10. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
11. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42.
Levi NL; Hanoch T; Benard O; Rozenblat M; Harris D; Reiss N; Naor Z; Seger R
Mol Endocrinol; 1998 Jun; 12(6):815-24. PubMed ID: 9626657
[TBL] [Abstract][Full Text] [Related]
13. Delayed and persistent ERK1/2 activation is required for 4-hydroxytamoxifen-induced cell death.
Zhou JH; Yu DV; Cheng J; Shapiro DJ
Steroids; 2007 Oct; 72(11-12):765-77. PubMed ID: 17714751
[TBL] [Abstract][Full Text] [Related]
14. Expression of Galpha 13 (Q226L) induces P19 stem cells to primitive endoderm via MEKK1, 2, or 4.
Wang HY; Kanungo J; Malbon CC
J Biol Chem; 2002 Feb; 277(5):3530-6. PubMed ID: 11700306
[TBL] [Abstract][Full Text] [Related]
15. The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways.
Boldt S; Weidle UH; Kolch W
Exp Cell Res; 2003 Feb; 283(1):80-90. PubMed ID: 12565821
[TBL] [Abstract][Full Text] [Related]
16. Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling.
Zhang Y; Neo SY; Wang X; Han J; Lin SC
J Biol Chem; 1999 Dec; 274(49):35247-54. PubMed ID: 10575011
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin.
Mabuchi S; Ohmichi M; Kimura A; Ikebuchi Y; Hisamoto K; Arimoto-Ishida E; Nishio Y; Takahashi K; Tasaka K; Murata Y
Endocrinology; 2004 Mar; 145(3):1302-13. PubMed ID: 14645110
[TBL] [Abstract][Full Text] [Related]
18. Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis.
Zhang CC; Shapiro DJ
J Biol Chem; 2000 Jan; 275(1):479-86. PubMed ID: 10617642
[TBL] [Abstract][Full Text] [Related]
19. MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells.
Garrington TP; Ishizuka T; Papst PJ; Chayama K; Webb S; Yujiri T; Sun W; Sather S; Russell DM; Gibson SB; Keller G; Gelfand EW; Johnson GL
EMBO J; 2000 Oct; 19(20):5387-95. PubMed ID: 11032806
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of urokinase-type plasminogen activator receptor expression by PMA requires JNK1-dependent and -independent signaling modules.
Gum R; Juarez J; Allgayer H; Mazar A; Wang Y; Boyd D
Oncogene; 1998 Jul; 17(2):213-25. PubMed ID: 9674706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
